MedPath

Evaluation of the effect of lemon balm plant on primary blood pressure control

Phase 3
Recruiting
Conditions
Hypertension.
Essential (primary) hypertension
Registration Number
IRCT20170820035796N2
Lead Sponsor
Sari University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
48
Inclusion Criteria

Men and women 30-75 years old
??Systolic blood pressure greater than or equal to 140, and diastolic blood pressure greater than or equal to 90 mmHg being treated with blood pressure medication (one to three drugs based on the protocol), but the patient’s blood pressure is uncontrolled
At least one month has elapsed since the onset of drug use
Have informed consent to participate in the study.

Exclusion Criteria

Blood pressure equal to or greater than 110/180 at the start of the study or during intervention
History of secondary hypertension
Major symptoms of major organ damage (such as renal failure, congestive heart failure, myocardial infarction, or cerebrovascular accidents) During the 6 months before the study
The presence of any type of cardiac arrhythmia (such as second- or third-degree blocks)
Symptomatic valvular disease
Liver dysfunction
Type 1 and type 2 diabetic patients with impaired renal and liver function to the extent that clinically significant (ie more than 1.5 times the maximum normal creatinine and alanine aminotransferase more than 3 times the normal maximum)
Low platelet count More than 100,000 per microliter of blood
History of treated or untreated malignancies
Potassium greater than 1.5 or less than 3.5 mg / L in the first visit
History of hypothyroidism or hyperthyroidism
Pregnancy and lactation
The presence of any medical or surgical disorder that could interfere with the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: In baseline and 5 times follow up measurement every 2 weeks. Method of measurement: Sphygmomanometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath